Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Journal of Biological Chemistry|May 29, 2014
Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growthNaoko Kubo Birukawa, Kazuyuki Murase, Yasushi Sato, et al.
Experimental and Molecular Pathology|October 19, 2010
The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinomaSatoko Inoda, Rena Morita, Yoshihiko Hirohashi, et al.
Cancer Research|May 4, 2012
HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cellsSatoshi Nishizawa, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Plos One|December 10, 2016
Involvement of Pancreatic Stellate Cells in Regeneration of Remnant Pancreas after Partial PancreatectomyShigenori Ota, Miyuki Nishimura, Yuya Murakami, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinomaSatoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteinsSatomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Oncotarget|July 16, 2016
Plasticity of lung cancer stem-like cells is regulated by the transcription factor HOXA5 that is induced by oxidative stressHiroshi Saijo, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Journal of Translational Medicine|June 15, 2004
Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancerTetsuhiro Tsuruma, Fumitake Hata, Toshihiko Torigoe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of ImmunotherapyRena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Pageof 10